FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
about
Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemiasPrognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia.Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaFlt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activityIntegrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaKIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemiaMechanisms of resistance to FLT3 inhibitors.Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects.Mouse models for core binding factor leukemia.Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia.Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).Leukemogenic potency of the novel FLT3-N676K mutant.CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice.Identification of a germline F692L drug resistance variant in cis with Flt3-internal tandem duplication in knock-in miceMyeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.
P2860
Q30252938-5C43D242-4C8F-430F-9FDE-D886956F83ACQ34169601-C6E65672-32BB-42BF-B792-E0BAC0AAD6B3Q34285937-AC1D4B46-3132-46F1-8FC2-D7FA39DA9AE1Q34598109-3D264CF7-E715-43A0-80CA-1A0474F9853EQ34709391-49F74543-C4B3-4484-B1FE-8659239D8F82Q35134457-92BCC1FD-5758-4E8D-83CA-F48EB08C232DQ35265916-38735C70-FE78-4A48-894C-D8D97B9A4E25Q35776437-39273814-1429-43EF-BD6D-665FD0B95F94Q36322776-F16F9854-84BD-4781-9811-2EE76D8BE29FQ37064640-FE0E68C7-F642-4F15-962C-5D1D73586DCDQ37375423-44E4532B-FFFC-49C9-98D9-FEEB98DACA1DQ37662400-A6D17F7E-1319-4FBC-8A3C-2AC778EA9756Q37871413-E9DF58DD-D6C0-48EE-B386-F247438D8017Q38545496-561D1599-ECBD-4095-8161-E2D51F26474BQ38865256-846D3180-99AD-4926-A062-9863D68BA9D9Q38879091-5F48415B-B3D7-4F78-82C8-BE25418B2228Q40901421-54C90A0F-93BC-4E31-8B9E-7A92B61DC6E4Q41108279-EB3EA6D5-1EAB-4CCB-9342-193241D1809DQ42391590-C8FC0BB3-BD05-4EA4-B264-F724822DE7CFQ48171349-A658F1B3-FCF9-4E94-BB3B-33E9F6B99EEAQ53821842-6BB1776D-5C03-45A4-9FA6-70F920EE22C8
P2860
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
@ast
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
@en
type
label
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
@ast
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
@en
prefLabel
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
@ast
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
@en
P2093
P2860
P1433
P1476
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia
@en
P2093
C Scott Swindle
Christopher A Klug
Claudiu V Cotta
Hyung-Gyoon Kim
Kyoko Kojima
Yongliang Huo
P2860
P304
P356
10.1182/BLOOD-2006-06-030312
P407
P577
2007-10-29T00:00:00Z